These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23930246)

  • 1. The influence of ureteral orifice configuration on the success rate of endoscopic treatment of vesicoureteral reflux.
    Alizadeh F; Shahdoost AA; Zargham M; Tadayon F; Joozdani RH; Arezegar H
    Adv Biomed Res; 2013; 2():1. PubMed ID: 23930246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic Correction of Reflux Utilizing Polyacrylate Polyalcohol Bulking Copolymer (Vantris) as a Tissue Augmenting Substance: Lessons Learned Over the 10 Years of Experience.
    Dothan D; Kocherov S; Jaber J; Chertin B
    J Laparoendosc Adv Surg Tech A; 2021 Sep; 31(9):1073-1078. PubMed ID: 34161157
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris).
    Warchol S; Krzemien G; Szmigielska A; Bombinski P; Brzewski M; Dudek-Warchol T
    J Pediatr Urol; 2016 Aug; 12(4):256.e1-4. PubMed ID: 27593921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.
    Kocaoglu C
    J Pediatr Surg; 2016 Oct; 51(10):1711-5. PubMed ID: 27117052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between dextranomer/ hyaluronic acid and polyacrylate polyalcohol copolymer as bulking agents for treating primary vesicoureteral reflux.
    Alizadeh F; Omidi I; Haghdani S; Hatef Khorrami M; Izadpanahi MH; Mohammadi Sichani M
    Urol J; 2019 May; 16(2):174-179. PubMed ID: 30178456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population?
    Chertin B; Mele E; Kocherov S; Zilber S; Gerocarni Nappo S; Capozza N
    J Pediatr Urol; 2018 Dec; 14(6):538.e1-538.e7. PubMed ID: 29885870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic correction of vesicoureteral reflux in children using polyacrylate-polyalcohol copolymer (Vantris): 5-years of prospective follow-up.
    Warchoł S; Krzemień G; Szmigielska A; Bombiński P; Toth K; Dudek-Warchoł T
    Cent European J Urol; 2017; 70(3):314-319. PubMed ID: 29104797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic correction of primary VUR by using polyacrylate polyalcohol copolymer (Vantris) in young girls: 2-year follow-up.
    Sharifiaghdas F; Tajalli F; Otukesh H; Shamsabadi RH
    J Pediatr Urol; 2014 Dec; 10(6):1032-6. PubMed ID: 24953543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer (Vantris®).
    Alizadeh F; Mazdak H; Khorrami MH; Khalighinejad P; Shoureshi P
    J Pediatr Urol; 2013 Aug; 9(4):488-92. PubMed ID: 23219423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).
    García-Aparicio L; Blázquez-Gómez E; Martin O; Pérez-Bertólez S; Arboleda J; Soria A; Tarrado X
    World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary data on endoscopic treatment of vesicoureteric reflux with polyacrylate polyalcohol copolymer (Vantris®): surgical outcome following single injection.
    Chertin B; Arafeh WA; Zeldin A; Kocherov S
    J Pediatr Urol; 2011 Dec; 7(6):654-7. PubMed ID: 21195029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between ureteric orifice morphology and primary vesicoureteral reflux grade and the impact on the effectiveness of endoscopic reflux correction.
    Zvizdic Z; Catic A; Zivojevic S; Jonuzi A; Glamoclija U; Vranic S
    J Pediatr Urol; 2024 Apr; 20(2):295-301. PubMed ID: 37940510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally Invasive Treatment of Vesico-ureteral Reflux Using Endoscopic Injection of Polyacrylate-Polyalcohol Copolymer (Vantris) in Patients After Kidney Transplantation.
    Frankiewicz M; Gawlik-Jakubczak T; Kostro J; Matuszewski M
    Transplant Proc; 2020 Oct; 52(8):2436-2439. PubMed ID: 32299710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic treatment of primary vesicoureteral reflux in children with two different bulking agents, high success and low complication rates: Comparison of Dexell and Vantris.
    Doğan AB; Özkan KU; Güler AG; Karakaya AE
    Actas Urol Esp (Engl Ed); 2021 Oct; 45(8):545-551. PubMed ID: 34526255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris).
    Kocherov S; Ulman I; Nikolaev S; Corbetta JP; Rudin Y; Slavkovic A; Dokumcu Z; Avanoglu A; Menovshchikova L; Kovarskiy S; Skliarova T; Weller S; Bortagaray JI; Lopez JC; Durán V; Burek C; Sager C; Maruhnenko D; Garmanova T; Djamal A; Jovanovic Z; Vacic N; Abu Arafeh W; Chertin B
    Urology; 2014 Sep; 84(3):689-93. PubMed ID: 25168553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic treatment of primary vesicoureteral reflux in children with two different bulking agents, high success and low complication rates: comparison of Dexell and Vantris.
    Doğan AB; Özkan KU; Güler AG; Karakaya AE
    Actas Urol Esp (Engl Ed); 2021 Jun; ():. PubMed ID: 34120775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic correction of complex cases of vesicoureteral reflux utilizing Vantris as a new non-biodegradable tissue-augmenting substance.
    Chertin B; Abu Arafeh W; Kocherov S
    Pediatr Surg Int; 2014 Apr; 30(4):445-8. PubMed ID: 24448911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
    Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
    J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of Treatment of Grades IV and V Vesicoureteral Reflux with Endoscopic Injection of Polyacrylate Polyalcohol Copolymer.
    De Badiola FI; Soria R; Vagni RL; Ormaechea MN; Moldes JM; Benmaor C
    Front Pediatr; 2013; 1():32. PubMed ID: 24400278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study using a new bulking agent for the treatment of vesicoureteral reflux: polyacrylamide hydrogel.
    Cloutier J; Blais AS; Moore K; Bolduc S
    J Urol; 2013 Sep; 190(3):1034-7. PubMed ID: 23538241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.